Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
•
Hospital Medicine
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
Related Questions
What is the stepwise investigation of patients suspected of inflammatory myopathy?
Do you routinely perform muscle biopsies in patients presenting with the classic symptoms of Inclusion Body Myositis along with positive CN1A antibody?
When and how do you deviate from efgartigimod (Vyvgart) dosing from the drug label recommendation of weekly infusions for four weeks in patients with myasthenia gravis?
How do you adjust dosing of rozanolixizumb for MG patients who deterioriate before the minimum re-dosing period?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
How do you counsel patients with mild congenital myopathy about exercise limitations?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
In a non-intubated patient with refractory status epilepticus whose wishes are clearly stated as DNR/DNI but would want all other medical therapies, have you used ketamine as a potential option, and does the dose range differ for non-intubated patients?
How do you manage neurologic complications of lithium toxicity?
How do you identify patients with false positive AcHR antibodies?
